Bovinium – Therapeutic Use of Antibiotics in BRD
This June, we find the 19th installment of Respivisuals. In this section, through audiovisual material, the second part on the therapeutic use of antibiotics in Bovine Respiratory Disease (BRD) is presented. The content analyzes why many therapeutic protocols end in failure.
Additionally, Valentín Pérez, Professor of Pathological Anatomy at the Faculty of Veterinary Medicine of the University of León, shares his knowledge and professional experience in Protagonists. Thus, Valentín uses his intervention to analyze the importance of pathoanatomical diagnosis in Bovine Respiratory Disease and how it can assist clinical veterinarians in their daily work.
Alongside the new materials, Bovinium always stays up to date with news and calendar. An opportunity to learn about the latest in everything related to BRD thanks to a selection of the most outstanding news and a calendar of events related to the bovine sector.
More information at www.bovinium.es Enter and register to become part of the Bovinium community!
Boehringer Ingelheim is the second largest animal health business in the world. The company is committed to the development of the future and animal welfare through a broad portfolio of advanced health products and services based on prevention. With net sales of € 3.9 billion and around 10,000 employees worldwide, we are present in more than 150 markets.
